Grande Laura J, Crosson Bruce, Heilman Kenneth M, Bauer Russell M, Kilduff Patrick, McGlinchey Regina E
Geriatric Research Education and Clinical Center, Boston VA Healthcare System, and Department of Psychiatry, Harvard Medical School, Boston, MA 02130, USA.
Neuropsychology. 2006 May;20(3):370-82. doi: 10.1037/0894-4105.20.3.370.
Impairment in the inhibitory mechanism of visual selective attention in patients with Parkinson's disease (PD) is controversial. The present study sought to understand disparate findings in a manner analogous to the relative preservation of exogenously evoked movement and impairment of endogenously evoked movement. The authors examined inhibition of return (i.e., exogenously evoked inhibition; IOR) and negative priming (i.e., endogenously evoked inhibition; NP) in a group of 14 patients with PD and 14 healthy controls (HC). Unlike the HC, who demonstrated significant inhibition in both tasks, the group with PD demonstrated intact inhibition only in the IOR task. Dopamine replacement therapy did not affect performance. The findings are discussed within the context of a model that differentiates the essential involvement of the basal ganglia for endogenously evoked spatial inhibition.
帕金森病(PD)患者视觉选择性注意抑制机制的受损情况存在争议。本研究试图以类似于对外源性诱发运动的相对保留和内源性诱发运动的受损的方式来理解不同的研究结果。作者在一组14名帕金森病患者和14名健康对照者(HC)中检测了返回抑制(即外源性诱发抑制;IOR)和负启动效应(即内源性诱发抑制;NP)。与在两项任务中均表现出显著抑制的健康对照者不同,帕金森病组仅在IOR任务中表现出完整的抑制。多巴胺替代疗法并未影响表现。这些发现是在一个区分基底神经节对内源性诱发空间抑制的必要参与的模型背景下进行讨论的。